BridgeMD
New treatment option for Iron Deficiency Anemia Treatment
Official title Alternative vs. Once-Daily Oral Iron Supplementation in Iron Deficiency Anemia (IDA)
ClinicalTrials.gov ID: NCT07014371
What this study is testing
What is Ferrous Fumarate Oral Tablet?
Ferrous Fumarate Oral Tablet is an investigational medicine, given as an once-daily pill taken by mouth, being studied as a potential treatment for iron deficiency anemia treatment.
Also referred to as Ferrous Fumarate 200 mg tablet, Oral iron supplement.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The goal of this clinical trial is to compare the effectiveness and tolerability of two different oral iron regimens in adults with iron deficiency anemia (IDA). The main questions it aims to answer are: Is alternate-day oral iron supplementation as effective as once-daily dosing in improving hemoglobin levels?
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 and older
You may be able to join if
- Male or female patients aged ≥20 years diagnosed with iron deficiency anemia, defined as: hemoglobin (Hb) \<13 g/dL in males or \<12 g/dL in females...
- No iron supplementation within the past 3 months.
You likely can't join if
- Hemodynamic instability (e.g., acute bleeding or hypotension).
- Severe heart failure (New York Heart Association [NYHA] Class III-IV) or other active cardiac diseases.
- Active malignancy or history of cancer within the past 3 years (except non-melanoma skin cancer).
- Pregnancy or breastfeeding.
- Chronic liver disease including cirrhosis (Child-Pugh class B or C).
- Chronic kidney disease (estimated glomerular filtration rate [eGFR] \<60 mL/min/1.73 m²).
See the full eligibility criteria
- Male or female patients aged ≥20 years diagnosed with iron deficiency anemia, defined as: hemoglobin (Hb) \<13 g/dL in males or \<12 g/dL in females, and ferritin \<50 ng/mL or transferrin saturation (TSAT) \<20%.
- No iron supplementation within the past 3 months.
- Hemodynamic instability (e.g., acute bleeding or hypotension).
- Severe heart failure (New York Heart Association [NYHA] Class III-IV) or other active cardiac diseases.
- Active malignancy or history of cancer within the past 3 years (except non-melanoma skin cancer).
- Pregnancy or breastfeeding.
- Chronic liver disease including cirrhosis (Child-Pugh class B or C).
- Chronic kidney disease (estimated glomerular filtration rate [eGFR] \<60 mL/min/1.73 m²).
- Clinically significant thalassemia or hemoglobinopathies.
- Ongoing infection or chronic inflammatory diseases (e.g., rheumatoid arthritis, inflammatory bowel disease).
- Malabsorption disorders (e.g., history of bariatric surgery).
- Red blood cell transfusion within the past 3 months. Withdrawal Criteria
- Withdrawal of informed consent.
- Severe adverse events requiring permanent discontinuation of study medication.
- Investigator's judgment that continued participation poses a safety risk.
- Non-adherence to study medication (compliance \< 75%). Treatment Failure \- Increase in hemoglobin level of \< 1 g/dL at Week 4 or Week 8 compared with baseline.
The study team makes the final eligibility decision.
Where it's taking place
- Bangkok, Thailand
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 20 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bangkok, Thailand. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.